The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology

• Published in: Journal of the American College of Cardiology Vol. 50; no. 19; pp. 1914 - 1931
• Main Authors: Cooper, Leslie T, Baughman, Kenneth L, Feldman, Arthur M, Frustaci, Andrea, Jessup, Mariell, Kuhl, Uwe, Levine, Glenn N, Narula, Jagat, Starling, Randall C, Towbin, Jeffrey, Virmani, Renu
• Format: Journal Article
• Language: English
• Published: United States Elsevier Limited 06.11.2007
• Subjects: Adult; Biopsy - adverse effects; Cardiology; Cardiomyopathies - pathology; Catheters; Child; Colleges & universities; Endocardium - pathology; Graft Rejection - pathology; Heart Failure - pathology; Heart Transplantation - pathology; Hospitals; Humans; Myocarditis - pathology; Myocardium - pathology; Societies, Medical; Veins & arteries
• ISSN: 0735-1097; 1558-3597
• DOI: 10.1016/j.jacc.2007.09.008

To define the current role of EMB in the management of cardiovascular disease, a multidisciplinary group of experts in cardiomyopathies and cardiovascular pathology was convened by the American Heart Association (AHA), the American College of Cardiology (ACC), and the European Society of Cardiology (ESC). Reviewer Employment Research Grant Other Research Support Speakers' Bureau/Honoraria Expert Witness Ownership Interest Consultant/ Advisory Board Other Mazen Abu-Fadel Ponca City Medical Center None None None None None None None Jeffrey Anderson LDS Hospital None None None None None None None Eloisa Arbustini I.R.C.C.S. Policlinico San Matteo, Pavia, Italy None None None None None None None Eric Bates University of Michigan None None None None None None None Fred Bove Temple University Penn Dept of Health None None None None Insight Telehealth Systems* None Rihal Charanjit Mayo Clinic None None None None None None None G. William Dec Massachusetts General Hospital None None None None None None None Jose Diez Baylor College of Medicine None None None None None Sanofi-Aventis* None Mark Eisenberg McGill University None None None None None None None Gerasimos Filippatos Evangelismos Hospital, Athens, Greece None None None None None None None Robert Harrington Duke University None None None None None None None Mark Hlatky Stanford University None None None None None None None Maryl Johnson University of Wisconsin None None None None None None None Jay Mason Covance Central Diagnostics None None None None None None None Walter Paulus VU University Medical Center, Netherlands None None None None None None None Richard Schofield University of Florida None None AstraZeneca*; AtCor Medical*; Novartis*; Pfizer*; Scios* None None Pfizer* None Udo Sechtem Robert-Bosch-Medical Center, Stuttgart, Germany None None None None None None None Ajay Shah King's College London None None None None None None None Samuel J. Shubrooks, Jr Beth Israel Deaconess Medical Center None None None None None None None * Reviewer Disclosures This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit.